These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11785695)

  • 1. Enhanced bioavailability of calcitonin formulated with alkylglycosides following nasal and ocular administration in rats.
    Ahsan F; Arnold J; Meezan E; Pillion DJ
    Pharm Res; 2001 Dec; 18(12):1742-6. PubMed ID: 11785695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of nasal salmon calcitonin absorption by lauroylcarnitine chloride in rats.
    Kagatani S; Shinoda T; Fukui M; Ohmura T; Hasumi S; Sonobe T
    Pharm Res; 1996 May; 13(5):739-43. PubMed ID: 8860430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nasal administration of low molecular weight heparin.
    Arnold J; Ahsan F; Meezan E; Pillion DJ
    J Pharm Sci; 2002 Jul; 91(7):1707-14. PubMed ID: 12115833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal delivery of PEGylated salmon calcitonins: hypocalcemic effects in rats.
    Lee KC; Park MO; Na DH; Youn YS; Lee SD; Yoo SD; Lee HS; DeLuca PP
    Calcif Tissue Int; 2003 Dec; 73(6):545-9. PubMed ID: 14508623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of salmon calcitonin particles for nasal delivery using spray-drying and novel supercritical fluid-assisted spray-drying processes.
    Cho W; Kim MS; Jung MS; Park J; Cha KH; Kim JS; Park HJ; Alhalaweh A; Velaga SP; Hwang SJ
    Int J Pharm; 2015 Jan; 478(1):288-296. PubMed ID: 25445994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chain length-dependent effects of alkylmaltosides on nasal absorption of enoxaparin.
    Mustafa F; Yang T; Khan MA; Ahsan F
    J Pharm Sci; 2004 Mar; 93(3):675-83. PubMed ID: 14762906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reestablishment of the nasal permeability barrier to several peptides following exposure to the absorption enhancer tetradecyl-beta-D-maltoside.
    Arnold JJ; Fyrberg MD; Meezan E; Pillion DJ
    J Pharm Sci; 2010 Apr; 99(4):1912-20. PubMed ID: 19894270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved nasal bioavailability of elcatonin by insoluble powder formulation.
    Ishikawa F; Katsura M; Tamai I; Tsuji A
    Int J Pharm; 2001 Aug; 224(1-2):105-14. PubMed ID: 11472819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing effect of chitosan on nasal absorption of salmon calcitonin in rats: comparison with hydroxypropyl- and dimethyl-beta-cyclodextrins.
    Sinswat P; Tengamnuay P
    Int J Pharm; 2003 May; 257(1-2):15-22. PubMed ID: 12711157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal absorption of salmon calcitonin.
    Kurose H; Seino Y; Shima M; Tanaka H; Ishida M; Yamaoka K; Yabuuchi H
    Calcif Tissue Int; 1987 Nov; 41(5):249-51. PubMed ID: 3121148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin delivery in nosedrops: new formulations containing alkylglycosides.
    Pillion DJ; Atchison JA; Gargiulo C; Wang RX; Wang P; Meezan E
    Endocrinology; 1994 Dec; 135(6):2386-91. PubMed ID: 7988421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of chitosan on the intranasal absorption of salmon calcitonin in sheep.
    Hinchcliffe M; Jabbal-Gill I; Smith A
    J Pharm Pharmacol; 2005 Jun; 57(6):681-7. PubMed ID: 15969922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled insulin is better absorbed when administered as a dry powder compared to solution in the presence or absence of alkylglycosides.
    Hussain A; Majumder QH; Ahsan F
    Pharm Res; 2006 Jan; 23(1):138-47. PubMed ID: 16320001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic long-chain alkyl maltosides and alkyl sucrose esters as enhancers of nasal insulin absorption.
    Pillion DJ; Ahsan F; Arnold JJ; Balusubramanian BM; Piraner O; Meezan E
    J Pharm Sci; 2002 Jun; 91(6):1456-62. PubMed ID: 12115845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intranasal absorption of various calcitonin spray preparations].
    Pisati P; Feletti F; De Bernardi M; Tripodi AS; Contos S; Germogli R; Molteni R; Covini D
    Boll Chim Farm; 1992 Mar; 131(3):120-7. PubMed ID: 1418891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved nasal absorption of salmon calcitonin by powdery formulation with N-acetyl-L-cysteine as a mucolytic agent.
    Matsuyama T; Morita T; Horikiri Y; Yamahara H; Yoshino H
    J Control Release; 2006 Oct; 115(2):183-8. PubMed ID: 16989920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The bioavailability of intranasal salmon calcitonin in healthy volunteers with and without a permeation enhancer.
    Lee WA; Ennis RD; Longenecker JP; Bengtsson P
    Pharm Res; 1994 May; 11(5):747-50. PubMed ID: 8058647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of nasal and intestinal calcitonin delivery by the novel Pheroid fatty acid based delivery system, and by N-trimethyl chitosan chloride.
    du Plessis LH; Lubbe J; Strauss T; Kotzé AF
    Int J Pharm; 2010 Jan; 385(1-2):181-6. PubMed ID: 19854253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylated beta-cyclodextrins are able to improve the nasal absorption of salmon calcitonin.
    Schipper NG; Verhoef JC; Romeijn SG; Merkus FW
    Calcif Tissue Int; 1995 Apr; 56(4):280-2. PubMed ID: 7767838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary absorption enhancement of salmon calcitonin.
    Mahesh Kumar T; Misra A
    J Drug Target; 2004 Apr; 12(3):135-44. PubMed ID: 15203892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.